KYTHERA to Float New Stock Issue

KYTHERA Biopharmaceuticals (NASDAQ: KYTH  ) is tapping the markets for a new dose of capital. The company announced it is floating a 2,622,950-share issue of its common stock at $45.75 per share in an underwritten public offering. Additionally, the company's underwriters have been granted a 30-day purchase option for up to an additional 393,442 shares.

KYTHERA said it plans to use "substantially all" of the estimated $112.2 million net proceeds of the issue for development. The remainder is to be utilized for working capital and "general corporate purposes."

JPMorgan Chase's (NYSE: JPM  ) J.P. Morgan Securities and Bank of America unit Merrill Lynch are the joint book-running managers of the issue, which is expected to close on or about October 15.

At the moment, KYTHERA has nearly 18.8 million shares outstanding, and its stock trades at $45.79 per share.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2675852, ~/Articles/ArticleHandler.aspx, 4/19/2014 6:32:09 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement